Cerebrospinal fluid concentrations of functionally important amino acids and metabolic compounds in patients with mild cognitive impairment and Alzheimer's disease.
about
Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.Serum Amino Acid Profiles in Normal Subjects and in Patients with or at Risk of Alzheimer DementiaBioAge: toward a multi-determined, mechanistic account of cognitive aging.Morphology, distribution and phenotype of polycystin kidney disease 2-like 1-positive cerebrospinal fluid contacting neurons in the brainstem of adult mice.Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's diseaseGraded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorderAβ Induces Excitotoxicity Mediated by APC/C-Cdh1 Depletion That Can Be Prevented by Glutaminase Inhibition Promoting Neuronal SurvivalMitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.New Functions of APC/C Ubiquitin Ligase in the Nervous System and Its Role in Alzheimer's Disease.Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers.Gaussian and linear deconvolution of LC-MS/MS chromatograms of the eight aminobutyric acid isomers.Elevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of Patients With Probable Alzheimer's Disease and Depression
P2860
Q26770781-BCBC8068-0A2B-4497-B7C8-F37B6F736404Q30845482-05CBF743-A646-4692-A398-6170338034CFQ33801596-4FB27910-5320-40BE-9E58-A8BF0687C5EDQ34644175-1DA70E82-9711-46E6-8FA2-C50107DB977DQ35087937-EB3F7133-7DC2-4501-8C34-C6E067486D9DQ36337525-9EF958AF-C216-4512-80BC-F7A9DB11BB4FQ36869854-FF4168C1-E18C-41CF-BB55-C9BE586193DBQ37169113-9CA7A30F-445D-40A9-93CA-2FDD000D75B4Q38962796-BF769608-075C-4CA2-895F-B8878AB1DE58Q39307016-9BEC975D-0D64-4949-A320-AE6BA1BE2CECQ47937645-0842F109-CD07-45FD-91CC-9D96E57F97C4Q50315099-49E5C25B-75EA-4627-8EFE-3586F483CDD6Q59128157-7EDBEE84-7829-42D8-85D2-D09741E7E330
P2860
Cerebrospinal fluid concentrations of functionally important amino acids and metabolic compounds in patients with mild cognitive impairment and Alzheimer's disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Cerebrospinal fluid concentrat ...... rment and Alzheimer's disease.
@en
Cerebrospinal fluid concentrat ...... rment and Alzheimer's disease.
@nl
type
label
Cerebrospinal fluid concentrat ...... rment and Alzheimer's disease.
@en
Cerebrospinal fluid concentrat ...... rment and Alzheimer's disease.
@nl
prefLabel
Cerebrospinal fluid concentrat ...... rment and Alzheimer's disease.
@en
Cerebrospinal fluid concentrat ...... rment and Alzheimer's disease.
@nl
P2093
P921
P356
P1476
Cerebrospinal fluid concentrat ...... rment and Alzheimer's disease.
@en
P2093
Elmar Kaiser
Johannes Schroeder
Peter Schoenknecht
Ralf Kinscherf
Stefan Kassner
Wulf Hildebrandt
P304
P356
10.1159/000287953
P577
2010-05-05T00:00:00Z